KYNU Gene - Kynureninase

Comprehensive genomic and functional analysis of the KYNU gene, its role in tryptophan metabolism, and associated diseases.

Gene Information Card

Symbol KYNU
Full Name Kynureninase
Gene Type Protein coding
Chromosomal Location 2q22.2
NCBI Gene ID 8942 ncbi.nlm.nih.gov/gene/8942
Ensembl ID ENSG00000115977
UniProt ID Q16719
OMIM ID 605197
HGNC ID 6469
Aliases LCCP, MGC88934

Description

The KYNU gene encodes kynureninase, a pyridoxal-5'-phosphate (PLP)-dependent enzyme that catalyzes the cleavage of L-kynurenine and L-3-hydroxykynurenine to anthranilic acid and 3-hydroxyanthranilic acid, respectively. This enzyme is a key component of the tryptophan degradation pathway via the kynurenine route, which ultimately leads to the synthesis of NAD+. Mutations in KYNU can cause hydroxykynureninuria, a rare autosomal recessive disorder characterized by intellectual disability and other neurological symptoms.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hydroxykynureninuria Loss-of-function mutations in KYNU impair the conversion of 3-hydroxykynurenine to 3-hydroxyanthranilic acid, leading to accumulation of kynurenine metabolites and neurological dysfunction. OMIM #236800; multiple case reports with biallelic pathogenic variants
NAD+ deficiency disorders Reduced kynureninase activity disrupts NAD+ biosynthesis from tryptophan, potentially contributing to pellagra-like symptoms. Inferred from metabolic pathway; limited direct evidence in patients

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Kidney 8.3 Medium
Brain 4.1 Medium
Lung 2.7 Low
Heart 1.9 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 Hepatocellular carcinoma cell line; high expression
HEK293 6.8 Embryonic kidney cells; moderate expression
SH-SY5Y 3.5 Neuroblastoma cell line; moderate expression
A549 2.1 Lung carcinoma; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.682C>T (p.Arg228*) Nonsense Rare Loss of function; premature stop codon
c.1015G>A (p.Gly339Arg) Missense Rare Reduced enzyme activity; associated with hydroxykynureninuria
c.1246C>T (p.Arg416Trp) Missense Rare Impaired PLP binding; loss of function
Mutation functional classification

Loss of Function (LOF)

Most reported pathogenic variants in KYNU are loss-of-function, leading to reduced or absent kynureninase activity and accumulation of upstream metabolites.

Gain of Function (GOF)

No gain-of-function mutations have been reported for KYNU.

Dominant Negative (DN)

No dominant-negative effects have been described; the disorder is autosomal recessive.

Pathways

Tryptophan metabolism (KEGG: hsa00380)
Nicotinate and nicotinamide metabolism (KEGG: hsa00760)
NAD+ biosynthesis from tryptophan (Reactome: R-HSA-196807)

Protein Summary

Kynureninase is a 465-amino-acid protein that functions as a homodimer. Each subunit binds one molecule of pyridoxal-5'-phosphate (PLP) as a cofactor. The enzyme catalyzes the hydrolytic cleavage of L-kynurenine and L-3-hydroxykynurenine, producing anthranilic acid and 3-hydroxyanthranilic acid, respectively. It is primarily expressed in liver and kidney, with lower levels in brain and other tissues. Defects in this enzyme lead to hydroxykynureninuria, a rare autosomal recessive disorder.

Related Products

Product name Cat.No. Species Gene ID
KYNU Knockout HEK293 Cell Line EDJ-KQ6412 Human 8942 Details Get a Quote
KYNU Knockout A-549 Cell Line EDJ-KQ30452 Human 8942 Details Get a Quote
KYNU Knockout HeLa Cell Line EDJ-KQ30453 Human 8942 Details Get a Quote
KYNU Knockout HCT 116 Cell Line EDJ-KQ71993 Human 8942 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: